Neutralization of (NK-cell-derived) B-cell activating factor by Belimumab restores sensitivity of chronic lymphoid leukemia cells to direct and Rituximab-induced NK lysis

DSpace Repository

Neutralization of (NK-cell-derived) B-cell activating factor by Belimumab restores sensitivity of chronic lymphoid leukemia cells to direct and Rituximab-induced NK lysis

Author: Wild, J.; Schmiedel, B. J.; Maurer, A.; Raab, S.; Prokop, L.; Stevanovic, S.; Doerfel, D.; Schneider, P.; Salih, H. R.
Tübinger Autor(en):
Salih, Helmut Rainer
Wild, Julia
Schmiedel, Benjamin J.
Maurer, Andreas
Raab, Stefanie
Prokop, Lea
Stevanović, Stefan
Dörfel, Daniela
Salih, Helmut Rainer
Published in: Leukemia (2015), Bd. 29, H. 8, S. 1676-1683
Verlagsangabe: Nature Publishing Group
Language: English
Full text: http://dx.doi.org/10.1038/leu.2015.50
ISSN: 0887-6924
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)